Literature DB >> 23090780

Optimal remifentanil dosage for intubation without muscle relaxants in elderly patients.

Eui-Kyoung Goo1, Ah-Young Oh, Suk-Ju Cho, Kwang-Suk Seo, Young-Tae Jeon.   

Abstract

BACKGROUND: Remifentanil used in combination with propofol provides adequate conditions for tracheal intubation without muscle relaxants. Delivery of the optimal dose is important to prevent poor intubation conditions and drug-related complications. No previous study has investigated the use of a remifentanil-propofol combination in elderly patients.
OBJECTIVE: The aim of the present study was to determine the dose of remifentanil necessary for rapid tracheal intubation without the use of muscle relaxants in elderly patients.
METHODS: A total of 24 patients >65 years of age with American Society of Anesthesiologists status I-II who were scheduled to undergo elective surgery under general anaesthesia were enrolled. After premedication with glycopyrrolate and midazolam, anaesthesia was induced with 1 mg/kg propofol, and a blinded dose of remifentanil was then infused over 30 s after confirming the patient's loss of consciousness. The remifentanil dose was determined using Dixon's up-and-down method, starting at 2 µg/kg. Intubation was performed 60 s after the loss of consciousness. Intubation conditions were assessed with the Stockholm score and an assessment of excellent or good condition was regarded as being clinically acceptable. The effective dose needed for acceptable intubation conditions in 50 % of the subjects (ED(50)) was determined by Dixon's up-and-down method, and the ED(50) and the effective dose needed for acceptable intubation conditions in 95 % of the subjects (ED(95)) with 95 % confidence intervals (CIs) were determined by probit analysis.
RESULTS: In total, 24 patients were recruited and the median age (interquartile range) was 70 (66-74) years. The ED(50) of remifentanil for tracheal intubation was 1.15 (standard deviation 0.13) µg/kg. The ED(50) and ED(95) of remifentanil obtained from the probit analyses were 1.16 (95 % CI 1.01, 1.29) µg/kg and 1.39 (95 % CI 1.27, 2.13) µg/kg, respectively. Blood pressure and heart rate decreased significantly after propofol and remifentanil administration, but were within 30 % of baseline values.
CONCLUSIONS: Combined with 1 mg/kg propofol, 1.39 (95 % CI 1.27, 2.13) µg/kg remifentanil resulted in acceptable intubation conditions within 60 s in 95 % of elderly patients without major complications.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23090780     DOI: 10.1007/s40266-012-0019-y

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  16 in total

Review 1.  The pharmacology of anesthetic drugs in elderly patients.

Authors:  S L Shafer
Journal:  Anesthesiol Clin North Am       Date:  2000-03

Review 2.  Staircase bioassay: the up-and-down method.

Authors:  W J Dixon
Journal:  Neurosci Biobehav Rev       Date:  1991       Impact factor: 8.989

3.  Comparison of two induction regimens using or not using muscle relaxant: impact on postoperative upper airway discomfort.

Authors:  X Combes; L Andriamifidy; E Dufresne; P Suen; S Sauvat; E Scherrer; P Feiss; J Marty; P Duvaldestin
Journal:  Br J Anaesth       Date:  2007-06-15       Impact factor: 9.166

4.  Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision.

Authors:  T Fuchs-Buder; C Claudius; L T Skovgaard; L I Eriksson; R K Mirakhur; J Viby-Mogensen
Journal:  Acta Anaesthesiol Scand       Date:  2007-08       Impact factor: 2.105

5.  Optimal remifentanil dosage for providing excellent intubating conditions when co-administered with a single standard dose of propofol.

Authors:  L Bouvet; A Stoian; T Rimmelé; B Allaouchiche; D Chassard; E Boselli
Journal:  Anaesthesia       Date:  2009-07       Impact factor: 6.955

6.  Comparison of different doses of remifentanil on the cardiovascular response to laryngoscopy and tracheal intubation.

Authors:  A P Hall; J P Thompson; N A Leslie; A J Fox; N Kumar; D J Rowbotham
Journal:  Br J Anaesth       Date:  2000-01       Impact factor: 9.166

7.  The influence of age on propofol pharmacodynamics.

Authors:  T W Schnider; C F Minto; S L Shafer; P L Gambus; C Andresen; D B Goodale; E J Youngs
Journal:  Anesthesiology       Date:  1999-06       Impact factor: 7.892

8.  Comparison of intubating conditions following propofol and succinylcholine with propofol and remifentanil 2 micrograms kg-1 or 4 micrograms kg-1.

Authors:  I A McNeil; B Culbert; I Russell
Journal:  Br J Anaesth       Date:  2000-10       Impact factor: 9.166

9.  Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application.

Authors:  C F Minto; T W Schnider; S L Shafer
Journal:  Anesthesiology       Date:  1997-01       Impact factor: 7.892

10.  Tracheal intubation without the use of muscle relaxants: remifentanil or alfentanil in combination with propofol.

Authors:  U M Klemola; S Mennander; L Saarnivaara
Journal:  Acta Anaesthesiol Scand       Date:  2000-04       Impact factor: 2.105

View more
  4 in total

1.  Comparison of intubating conditions after induction with propofol and remifentanil or sufentanil : Randomized controlled REMIDENT trial for surgical tooth extraction.

Authors:  A Dolsan; L Bruneteau; C Roche; F Ferré; F Labaste; A Sommet; J-M Conil; V Minville
Journal:  Anaesthesist       Date:  2020-02-28       Impact factor: 1.041

2.  Intubating conditions and side effects of propofol, remifentanil and sevoflurane compared with propofol, remifentanil and rocuronium: a randomised, prospective, clinical trial.

Authors:  Thomas Mencke; Refa Maria Jacobs; Susann Machmueller; Martin Sauer; Christine Heidecke; Anja Kallert; Hans Wilhelm Pau; Gabriele Noeldge-Schomburg; Attila Ovari
Journal:  BMC Anesthesiol       Date:  2014-05-22       Impact factor: 2.217

3.  The optimal exhaled concentration of sevoflurane for intubation without neuromuscular blockade using clinical bolus doses of remifentanil: A randomized controlled trial.

Authors:  Eui-Kyoung Goo; Jong Seok Lee; Jae Chul Koh
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  Evaluation of minimal dose of atracurium for cataract surgery in children: A prospective randomized double-blind study.

Authors:  Vanlal Darlong; Rakesh Garg; Ravinder Pandey; Sudarshan Khokhar; Renu Sinha; Jyotsna Punj; Rajesh Sinha
Journal:  Saudi J Anaesth       Date:  2015 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.